Literature DB >> 19092054

MHC class II transport at a glance.

Adam C Berger1, Paul A Roche.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19092054      PMCID： PMC2714400          DOI： 10.1242/jcs.035089

Source DB:  PubMed          Journal:  J Cell Sci        ISSN： 0021-9533            Impact factor:   5.285


× No keyword cloud information.
  30 in total

1.  Role of LBPA and Alix in multivesicular liposome formation and endosome organization.

Authors:  Hirotami Matsuo; Julien Chevallier; Nathalie Mayran; Isabelle Le Blanc; Charles Ferguson; Julien Fauré; Nathalie Sartori Blanc; Stefan Matile; Jacques Dubochet; Rémy Sadoul; Robert G Parton; Francis Vilbois; Jean Gruenberg
Journal:  Science       Date:  2004-01-23       Impact factor: 47.728

2.  AP2 clathrin adaptor complex, but not AP1, controls the access of the major histocompatibility complex (MHC) class II to endosomes.

Authors:  Marc Dugast; Hélène Toussaint; Christelle Dousset; Philippe Benaroch
Journal:  J Biol Chem       Date:  2005-03-04       Impact factor: 5.157

3.  Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape.

Authors:  Wilbert Zwart; Alexander Griekspoor; Coenraad Kuijl; Marije Marsman; Jacco van Rheenen; Hans Janssen; Jero Calafat; Marieke van Ham; Lennert Janssen; Marcel van Lith; Kees Jalink; Jacques Neefjes
Journal:  Immunity       Date:  2005-02       Impact factor: 31.745

4.  Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate.

Authors:  Lélia Delamarre; Margit Pack; Henry Chang; Ira Mellman; E Sergio Trombetta
Journal:  Science       Date:  2005-03-11       Impact factor: 47.728

5.  Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments.

Authors:  Peter J McCormick; José A Martina; Juan S Bonifacino
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

Review 6.  How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway.

Authors:  P R Wolf; H L Ploegh
Journal:  Annu Rev Cell Dev Biol       Date:  1995       Impact factor: 13.827

7.  Negative regulation by HLA-DO of MHC class II-restricted antigen processing.

Authors:  L K Denzin; D B Sant'Angelo; C Hammond; M J Surman; P Cresswell
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

Review 8.  Mhc-guided processing: binding of large antigen fragments.

Authors:  Eli E Sercarz; Emanual Maverakis
Journal:  Nat Rev Immunol       Date:  2003-08       Impact factor: 53.106

9.  Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes.

Authors:  P J Peters; G Raposo; J J Neefjes; V Oorschot; R L Leijendekker; H J Geuze; H L Ploegh
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

10.  Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments.

Authors:  M J Kleijmeer; S Morkowski; J M Griffith; A Y Rudensky; H J Geuze
Journal:  J Cell Biol       Date:  1997-11-03       Impact factor: 10.539
View more
  20 in total

1.  ITAM signaling in dendritic cells controls T helper cell priming by regulating MHC class II recycling.

Authors:  Daniel B Graham; Holly M Akilesh; Grzegorz B Gmyrek; Laura Piccio; Susan Gilfillan; Julia Sim; Roger Belizaire; Javier A Carrero; Yinan Wang; Gregory S Blaufuss; Gabriel Sandoval; Keiko Fujikawa; Anne H Cross; John H Russell; Marina Cella; Wojciech Swat
Journal:  Blood       Date:  2010-07-15       Impact factor: 22.113

2.  Hsp90-peptide complexes stimulate antigen presentation through the class II pathway after binding scavenger receptor SREC-I.

Authors:  Ayesha Murshid; Jianlin Gong; Stuart K Calderwood
Journal:  Immunobiology       Date:  2014-08-10       Impact factor: 3.144

3.  Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells.

Authors:  Berta Bosch; Adam C Berger; Sanjay Khandelwal; Erica L Heipertz; Brian Scharf; Laura Santambrogio; Paul A Roche
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

4.  Inhibition of CD1d-mediated antigen presentation by the transforming growth factor-β/Smad signalling pathway.

Authors:  Jennifer C Bailey; Abhirami K Iyer; Gourapura J Renukaradhya; Yinling Lin; Hoa Nguyen; Randy R Brutkiewicz
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

5.  Characterization of intracellular dynamics of inoculated PrP-res and newly generated PrP(Sc) during early stage prion infection in Neuro2a cells.

Authors:  Takeshi Yamasaki; Gerald S Baron; Akio Suzuki; Rie Hasebe; Motohiro Horiuchi
Journal:  Virology       Date:  2014-01-15       Impact factor: 3.616

6.  Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis.

Authors:  Aswin Hari; Anutosh Ganguly; Libing Mu; Shevaun P Davis; Melanie D Stenner; Raymond Lam; Fay Munro; Inana Namet; Enaam Alghamdi; Tobias Fürstenhaupt; Wei Dong; Pascal Detampel; Lian Jun Shen; Matthias W Amrein; Robin M Yates; Yan Shi
Journal:  Eur J Immunol       Date:  2014-12-08       Impact factor: 5.532

7.  Class II transactivator (CIITA) enhances cytoplasmic processing of HIV-1 Pr55Gag.

Authors:  Kristen A Porter; Lauren N Kelley; Annette George; Jonathan A Harton; Karen M Duus
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

8.  Predictor for the effect of amino acid composition on CD4+ T cell epitopes preprocessing.

Authors:  Ehud Hoze; Lea Tsaban; Yaakov Maman; Yoram Louzoun
Journal:  J Immunol Methods       Date:  2013-02-26       Impact factor: 2.303

9.  Discrete domains of MARCH1 mediate its localization, functional interactions, and posttranscriptional control of expression.

Authors:  Maurice Jabbour; Erin M Campbell; Hanna Fares; Lonnie Lybarger
Journal:  J Immunol       Date:  2009-10-30       Impact factor: 5.422

10.  Toll-like receptor 6 mediated inflammatory and functional responses of zinc oxide nanoparticles primed macrophages.

Authors:  Ruchi Roy; Sunil K Singh; Mukul Das; Anurag Tripathi; Premendra D Dwivedi
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.